Given Imaging

Minneapolis, United States Founded: 1998 • Age: 28 yrs Acquired By Covidien
Capsule endoscopy systems for GI imaging

About Given Imaging

Given Imaging is a company based in Minneapolis (United States) founded in 1998 was acquired by Covidien in December 2013. Given Imaging has completed 1 acquisition, including SmartPill. Given Imaging operates in a competitive market with competitors including Prometheus Laboratories, Viome Life Sciences, NinePoint Medical, InDex Pharmaceuticals and EnteraSense, among others.

Operational Areas
Key Metrics

Funding Insights of Given Imaging

  • Total Rounds 1
  • Last Round Post-IPO β€” $10M
  • First Round $10M

    (Aug 2006)

  • Investors Count 1

All 1 funding rounds of Given Imaging with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2006$10MPost-IPO––
Valuation history

2 investors in total: 2 institutional.

Investors in Given Imaging

Given Imaging has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Elron Ventures and Covidien.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital firm focused on early-stage technologies companies
1962elronventures.comTel Aviv, Israel
Medical devices for minimally invasive therapies are provided globally.
2007covidien.comDublin, Ireland
Premium access

Investor details for Given Imaging

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Given Imaging

Given Imaging has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include SmartPill.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Developer of monitoring device for detecting gastrointestinal disorders
smartpillcorp.comBuffalo, United States2005Oct 2012β€’β€’β€’β€’
Premium access

Complete acquisition details for Given Imaging

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Given Imaging

4 dated milestones of Given Imaging across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded Given Imaging is founded.
  2. Funding First funding round of $10.0M.
  3. Acquisition Acquires SmartPill.
  4. Exit Acquired by Covidien.

Competitors of Given Imaging

Given Imaging operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prometheus Laboratories, Viome Life Sciences, NinePoint Medical, InDex Pharmaceuticals and EnteraSense, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
prometheuslabs.com1995San Diego, United States–474
Diagnostics and therapeutics for gastrointestinal and personalized medicine are developed.
viomelifesciences.com2016Bothell, United States$92.44M136
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
ninepointmedical.com2008Bedford, United States$98.26M25
Optical coherence tomography systems for tissue microstructure imaging are developed.
indexpharma.com2000Stockholm, Sweden$45.42M–
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
enterasense.com2016Galway, Ireland$1.14M–
Ingestible biosensor for GI disease
gtechmedical.com2010Mountain View, United States$6.93M3
Diagnostic device company
xillix.com2002Toronto, Canada$5.5M–
Develops real-time fluorescence imaging systems for medical applications.
goodgut.eu2014Girona, Spain$900,240–
Diagnosis and treatment of digestive diseases based on intestinal microbiota analysis
stelladx.com2020New York, United States––
Molecular diagnostics solutions for esophageal diseases are developed.
Premium access

Detailed competitors of Given Imaging

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Given Imaging

Websites that share an audience with Given Imaging (givenimaging.com).

Similar websites

Websites whose visitors overlap most with Given Imaging. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
healthline.com
100%
53.9M#806View details
pillcamcolon.com
pillcamcolon.com
85%
–––
superdimension.com
superdimension.com
82%
–––
digestivehealth.ws
75%
–#2,215,139View details
nuvasive.com
74%
122.8K#333,205View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 15 similar websites and full traffic analytics for Given Imaging

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 15 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Given Imaging

Premium access

Complete news archive for Given Imaging

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Given Imaging

10 companies that operate in the same segment as Given Imaging (Gastroenterology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
1998Cambridge, Massachusetts, United StatesUSD 206.25 MUSD 296.15 M253
Implantable battery-powered pumps for ascites removal are developed.
2006Zurich, SwitzerlandUSD 35.5 M––
Sacral neuromodulation devices are developed for urinary and bowel control.
2013Irvine, California, United StatesUSD 143.47 M––
Provider of a deep learning platform for detecting circulating cancer-related markers
2014United StatesUSD 1.35 B–533
Developer of electrosurgical system and range of flexible endoscopic instruments
2003Chepstow, Monmouthshire, United KingdomUSD 20.84 MUSD 8.08 M141
Non-invasive biomarker tests for colorectal cancer are developed.
2015St. Louis, Missouri, United StatesUSD 218.95 M––
Pendulum is focused on developing advanced probiotic solutions.
2012San Francisco, California, United StatesUSD 109.5 M–55
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
2007Fremont, California, United StatesUSD 61.1 MUSD 407.32 M395
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
2009Ramat Gan, Tel Aviv District, IsraelUSD 13.5 MUSD 288.27 K35
Biologics are developed for cardio-metabolic and liver diseases.
2007San Francisco, California, United StatesUSD 358.87 MUSD 330.53 M–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Given Imaging

Given Imaging was founded in 1998 and raised its 1st funding round 8 years after it was founded.

Given Imaging is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.

Given Imaging develops and commercializes capsule endoscopy systems for imaging the gastrointestinal tract. Its proprietary Pillcam systems enable the surgeon to visualize the GI tract by using a pill that can be swallowed by the patient. Associated software allows the physician to view the Pillcam images in real-time and create study reports. In addition, the company also develops solutions for diagnosis of acid reflux, and motility monitoring. In Dec 2013, Given Imaging was acquired by Covidien for 860M.

Given Imaging's top competitors include Viome Life Sciences, Prometheus Laboratories and NinePoint Medical.

Given Imaging has made 1 acquisition, including SmartPill.

Given Imaging has 2 investors. Key investors include Elron Ventures, and Covidien.

Given Imaging operates through Given Imaging, Inc.

Yes. Given Imaging was acquired by Covidien in December 2013.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available